News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
531,213 Results
Type
Article (45081)
Company Profile (118)
Press Release (486014)
Multimedia
Podcasts (82)
Webinars (12)
Section
Business (145378)
Career Advice (2403)
Deals (27985)
Drug Delivery (120)
Drug Development (68340)
Employer Resources (152)
FDA (15685)
Job Trends (11985)
News (264584)
Policy (29712)
Tag
Academia (2305)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (81)
Alliances (36104)
ALS (87)
Alzheimer's disease (1436)
Antibody-drug conjugate (ADC) (134)
Approvals (15643)
Artificial intelligence (246)
Autoimmune disease (27)
Automation (12)
Bankruptcy (311)
Best Places to Work (9202)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (71)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (261)
Cancer (2132)
Cardiovascular disease (186)
Career advice (2010)
Career pathing (33)
CAR-T (144)
Cell therapy (412)
Cervical cancer (19)
Clinical research (55604)
Collaboration (715)
Compensation (530)
Complete response letters (29)
COVID-19 (2602)
CRISPR (43)
C-suite (223)
Cystic fibrosis (94)
Data (2022)
Decentralized trials (2)
Denatured (14)
Depression (52)
Diabetes (267)
Diagnostics (5273)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (101)
Drug pricing (122)
Drug shortages (30)
Duchenne muscular dystrophy (97)
Earnings (58969)
Editorial (44)
Employer branding (20)
Employer resources (137)
Events (77718)
Executive appointments (652)
FDA (16922)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (640)
Gene editing (103)
Generative AI (22)
Gene therapy (314)
GLP-1 (790)
Government (3911)
Grass and pollen (6)
Guidances (60)
Healthcare (14845)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (139)
Indications (26)
Infectious disease (2748)
Inflammatory bowel disease (131)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (89)
Interviews (450)
IPO (14009)
IRA (48)
Job creations (3162)
Job search strategy (1666)
Kidney cancer (11)
Labor market (32)
Layoffs (512)
Leadership (23)
Legal (6974)
Liver cancer (73)
Lung cancer (305)
Lymphoma (146)
Machine learning (7)
Management (52)
Manufacturing (292)
MASH (71)
Medical device (11230)
Medtech (11233)
Mergers & acquisitions (14483)
Metabolic disorders (726)
Multiple sclerosis (75)
NASH (22)
Neurodegenerative disease (99)
Neuropsychiatric disorders (33)
Neuroscience (1972)
NextGen: Class of 2025 (4998)
Non-profit (3185)
Now hiring (17)
Obesity (402)
Opinion (220)
Ovarian cancer (68)
Pain (87)
Pancreatic cancer (78)
Parkinson's disease (148)
Partnered (16)
Patents (232)
Patient recruitment (101)
Peanut (44)
People (42828)
Pharmaceutical (34)
Pharmacy benefit managers (21)
Phase I (16656)
Phase II (24081)
Phase III (19752)
Pipeline (1181)
Policy (166)
Postmarket research (2221)
Preclinical (6758)
Press Release (29)
Prostate cancer (106)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (394)
Real estate (4272)
Recruiting (60)
Regulatory (21002)
Reports (31)
Research institute (2063)
Resumes & cover letters (401)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (77)
Series A (123)
Series B (79)
Service/supplier (9)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (128)
Sponsored (33)
Startups (2757)
State (1)
Stomach cancer (16)
Supply chain (72)
Tariffs (45)
The Weekly (67)
Vaccines (768)
Venture capitalists (43)
Weight loss (293)
Women's health (31)
Worklife (20)
Date
Today (196)
Last 7 days (845)
Last 30 days (2487)
Last 365 days (29890)
2025 (10011)
2024 (31456)
2023 (35059)
2022 (45137)
2021 (48564)
2020 (45568)
2019 (36299)
2018 (27445)
2017 (27860)
2016 (25880)
2015 (28086)
2014 (21857)
2013 (17855)
2012 (19040)
2011 (19443)
2010 (17580)
Location
Africa (672)
Alabama (41)
Alaska (6)
Arizona (169)
Arkansas (10)
Asia (31212)
Australia (5480)
California (5562)
Canada (1521)
China (422)
Colorado (237)
Connecticut (270)
Delaware (133)
Europe (75990)
Florida (845)
Georgia (182)
Hawaii (1)
Idaho (36)
Illinois (447)
India (24)
Indiana (243)
Iowa (11)
Japan (147)
Kansas (84)
Kentucky (13)
Louisiana (7)
Maine (61)
Maryland (842)
Massachusetts (4197)
Michigan (180)
Minnesota (326)
Mississippi (1)
Missouri (70)
Montana (12)
Nebraska (19)
Nevada (56)
New Hampshire (51)
New Jersey (1578)
New Mexico (14)
New York (1550)
North Carolina (891)
North Dakota (6)
Northern California (2475)
Ohio (159)
Oklahoma (8)
Oregon (28)
Pennsylvania (1213)
Puerto Rico (9)
Rhode Island (21)
South America (1036)
South Carolina (21)
South Dakota (1)
Southern California (2091)
Tennessee (86)
Texas (783)
United States (20702)
Utah (146)
Virginia (130)
Washington D.C. (59)
Washington State (503)
West Virginia (3)
Wisconsin (54)
531,213 Results for "alk abello a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
April 30, 2025
·
1 min read
Press Releases
Annual General Meeting in ALK-Abelló A/S held on 13 March 2025
March 14, 2025
·
1 min read
Press Releases
Annual General Meeting in ALK-Abelló A/S on 13 March 2025
February 20, 2025
·
1 min read
Press Releases
Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
February 13, 2025
·
1 min read
Press Releases
ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S
January 6, 2025
·
8 min read
Press Releases
ALK’s pivotal phase 3 trial in children published in reputable scientific journal
November 27, 2024
·
6 min read
Press Releases
Invitation to the presentation of ALK’s results for the first nine months (Q3) 2024 on Thursday 14 November 2024
November 7, 2024
·
1 min read
Press Releases
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity
February 25, 2025
·
7 min read
Press Releases
Annual report 2024: ALK delivers 15% sales growth with profits up 65%
February 19, 2025
·
3 min read
Press Releases
U.S. FDA Approves Label Expansion for ALK’s ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy
February 28, 2025
·
10 min read
1 of 53,122
Next
